predominantly by local proliferation rather than circulatory monocyte renewal. 4 This new observation fits within an emerging understanding that diversity of tissue macrophage subsets may be aligned with different developmental origins. 5, 6 Classically activated, inflammatory macrophages are generally considered to derive from circulating monocytes, which descend from hematopoietic stem and progenitor cells (HPCs). In adult murine BM, Lin − Sca-1 − c-Kit +/Int CD135 + CD115 + CX 3 CR1 + macrophage/dendritic cell progenitors (MDPs) have been identified as the common precursor for circulating monocytes and their macrophage and dendritic cell progeny, 7 with recent evidence placing Lin − c-Kit + CD135 − CD115 + Ly6C + CD11b − common monocyte progenitors (cMoPs) as the link between MDPs and monocytes. 8
M embers of the mononuclear phagocyte system (MPS), including macrophages and dendritic cells, mediate innate immunity and coordinate the regulation of inflammation. In the vasculature, cells of the MPS regulate vascular form and function in health and disease, highlighted by their role in atherosclerosis. While intimal macrophages are considered as a source of foam cells in atheroma, 1 adventitial macrophages also initiate plaque formation via stimulation of angiogenesis 2 and participate in the pathogenesis of inflammatory vasculopathies and aneurysm formation. 3 Although the existing paradigm of macrophage origins in vascular disease emphasizes recruitment of bone marrow (BM)-or splenic-derived monocytes via the circulation, 1 recent data suggest that in established atheroma, macrophage burden may be maintained Despite this hierarchy of BM monocyte-macrophage ancestry, the origin of some tissue macrophages, including those belonging to the alternatively activated pathway, is less clearly defined. During prenatal development, F4/80 Bright macrophages arise in different organs through a process that originates in the yolk sac before the onset of definitive hematopoiesis. 9 Postnatally, the renewal, maintenance, and proliferation of certain tissue-resident macrophages occur locally, largely autonomous of BM hematopoiesis and circulatory monocyte recruitment. 6, [10] [11] [12] To date, this has been attributed to a remarkable capacity for mature tissue macrophages to undergo selfrenewal, enabling them to proliferate indefinitely without loss of functional differentiation, through uncoupling of differentiation and cell cycle withdrawal by the inactivation of specific transcription factors. 13 However, another explanation for the local proliferation and turnover of postnatal tissue macrophages, previously untested, is the existence of tissue-resident macrophage progenitor cells. With increasing recognition that postnatal blood vessels contain resident populations of diverse progenitor cell populations, 14 we recently identified that murine arteries contain clonogenic cells of hematopoietic significance. 15 Here, we phenotypically, transcriptionally, and functionally characterize a population of resident adventitial macrophage progenitor cells (AMPCs) within healthy and atherosclerotic vasculature and determine their noncirculatory origins, as well as their capacity to generate macrophage and dendritic cell progeny.
Methods
Detailed methods are provided in the Online Data Supplement. Single-cell tissue disaggregates were prepared from mice belonging to C57BL/6, ApoE −/− , LDL-R −/− , green fluorescent protein (GFP), and op/op (C3Fe a/a-Csf1op/CSF1op) strains under age and dietary conditions specified below. Hematopoietic colony-forming unit (CFU) assays, flow cytometry analysis, BM and splenic cell adoptive transfer experiments, and tissue immunostaining were performed using techniques described previously. 15 Magnetic-activated cell sorting was used to fractionate freshly isolated aortic disaggregates into subpopulations based on expression of stem cell antigen-1 (Sca-1 or Ly6A) and the pan-leukocyte marker, CD45. These different aortic cell subsets were compared for (1) clonogenicity and cell cycle activity, (2) transcriptional profiling by RNA microarray and quantitative reverse transcription polymerase chain reaction validation, (3) expression of surface markers associated with macrophage ancestry in BM, and (4) long-term in vivo fate after carotid artery adventitial transfer to atheroprone recipients. All experiments complied with the standards stated in the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, National Academy of Sciences, Bethesda, MD) and were approved by the Mayo Clinic Institutional Animal Care and Use Committee.
Statistical Analysis
Comparisons were performed with parametric or nonparametric unpaired or paired 2-sample t tests or ANOVA (with post-test comparisons), as appropriate. Results are expressed as mean±SEM of multiple experiments, unless otherwise specified. In all cases, statistical significance was established at 2-tailed P<0.05.
Results

Adventitial Sca-1 + CD45 + Cells Contain Macrophage Progenitors
To understand the context and specificity of the hematopoietic potential of aorta, short-term CFU assays were performed on freshly isolated, single-cell preparations of various hematopoietic and nonhematopoietic adult C57BL/6 murine tissues. As described previously, 15 great care was taken to avoid peripheral blood contamination of aortic extracts, and this was verified in numerous ways, including the use of flow cytometry (Online Figure I ). 16 Enzymatic digestion of fulllength aorta from 12-week-old C57BL/6 mice yielded 1.5 to 2×10 6 cells. Although all tissues tested generated CFUs to a varying degree, aortic cells were distinguished by a robust hematopoietic CFU capacity, which was notable for their distinct predisposition to generate lineage-specific macrophage colonies (CFU-M) at a mean frequency of 13.7±1.4 per 10 5 aortic cells plated (n=11) or ≈200 to 300 per aorta ( Figure 1A ). In addition to fulfilling conventional morphological criteria, the MPS-enriched content of aortic CFU assays was supported by their substantial upregulation of macrophage and dendritic cell marker expression after 14 days of culture in methylcellulose, with absence of granulocytes ( Figure 1B ). Unlike aorta, CFUs generated from BM, peripheral blood, and spleen comprised much higher proportions of multilineage CFU-GM (granulocyte-macrophage) and -GEMM (granulocyte, erythrocyte, monocyte, megakaryocyte), along with CFU-G (granulocyte) and BFU-E (burst forming units-erythroid).
Previously, we established that arterial capacity for CFU formation is predominantly contained within the adventitial subpopulation of cells expressing Sca-1. 15 As others have reported that adventitial Sca-1 + Lineage − CD45 − cells possess smooth muscle differentiation potential but lack hematopoietic clonogenicity, 17, 18 we focused on the previously unstudied population of adventitial Sca-1 + CD45 + cells. By flow cytometry, CD45 expression was present on 35.9±4.7% of Sca-1 + cells from C57BL/6 aortas (n=15; Figure 1C ). Coexpression of Sca-1 and CD45 in healthy murine aorta was independently confirmed by tissue immunofluorescence and shown to be predominantly contained within the adventitia ( Figure 1D , Online Figure II ). Magnetic separation of the Sca-1 + CD45 + subset of aortic cells resulted in 4-fold enrichment in hematopoietic CFU yield ( Figure 1E , Online Figure  III) . These CFUs were exclusively CFU-M, which were more commonly of larger size than those from unfractionated cultures ( Figure 1F By comparison to aortic Sca-1 + CD45 + cells, hematopoietic colony formation was nearly absent from the Sca-1 + CD45 − fraction, consistent with previous depictions that these cells harbor smooth muscle and not hematopoietic progenitor capacity. 17, 18 Critically, colony formation was also 16-fold less from resident Sca-1 − CD45 + cells, with 25% of these colonies comprising CFU-GM and -GEMM. The much lower yield of CFU-M from Sca-1 − CD45 + cells was in spite of this population containing a higher frequency of Lin − CD11b Hi F4/80 Lo monocytes than the Sca-1 + CD45 + subset ( Figure 1G ). Along with the fact that CFU-M were generated at low frequency from peripheral blood ( Figure 1A ), this provided initial evidence that the cells responsible for arterial macrophage colonies are not monocytes, consistent with recent data showing the nonmonocyte origins of tissue-resident macrophages. 9, 11, 12 This was supported in separate experiments in which freshly disaggregated aortic cells were subjected to magnetic sorting on the basis of their expression of a panel of lineage markers, which included the monocyte/macrophage antigen CD11b, along with CD5, CD19, CD45R, Gr-1, Ter119. CFU-M were almost exclusively retrieved from the lineage-depleted fraction, with negligible CFU-M recovery from the lineagepositive cells which included CD11b + monocytes and macrophages (Online Figure V) .
Together with augmented CFU-forming ability, the adventitial Sca-1 + CD45 + compartment also contained the highest proportion of actively cycling cells in aorta, as corroborated by Ki67 staining analyzed by flow cytometry of aortic disaggregates ( Figure 1H ) and tissue immunostaining (Online Figure VI) , and bromodeoxyuridine incorporation ( Figure 1I , Online Figure VI ). The mean rate of apoptosis, as determined by annexin V and 7-amino-actinomycin D (7AAD) uptake, was ≈10% for aortic Sca-1 + CD45 + cells and did not differ significantly with aging (Online Figure VII) . Thus, aortic adventitia is enriched in macrophage progenitors that reside in the population of proliferative Sca-1 + CD45 + cells.
Genomic and Phenotypic Characterization of Aortic Sca-1 + CD45 + Cells
To further understand the innate differences among aortic cell populations according to their Sca-1 and CD45 expression, we performed, analyzed, and validated nonbiased transcriptional profiles of disaggregated aortic cells. Unsupervised clustering analysis of genome-wide expression arrays indicated that the combined presence of Sca-1 and CD45 was associated with extensive differences in the transcriptional profile of aortic cells (Figure 2A -2C, Online Table I ). There were 44 genes that were upregulated in Sca-1 + CD45 + cells compared with both the Sca-1 − CD45 + (resident leukocytes) and Sca-1 + CD45 − (smooth muscle progenitor) fractions, including those that encode Csf2 (granulocyte-macrophage colony-stimulating factor), 12) , and Gata3. Many other genes were differentially regulated between Sca-1 + CD45 + cells and each of the other 2 populations, with 879 and 552 genes upregulated by a factor of ≥2-fold Figure 2 . RNA microarray profiling of different stem cell antigen-1 (Sca-1)/CD45 fractions of aortic cells. Volcano plots (A) and heat map (B) from RNA microarray showing differential gene expression between Sca-1 + CD45 + , Sca-1 − CD45 + and Sca-1 + CD45 − aortic cells. C, Unsupervised clustering analysis of genome-wide expression arrays indicated that the combined presence of stem cell antigen-1 (Sca-1) and CD45 was associated with extensive differences in the genomic imprint of aortic cells compared with Sca-1 − CD45 + and Sca-1 + CD45 − cells, respectively. D and E, Histograms from Ingenuity analysis depict the top 10 biological pathways that had differential gene regulation between aortic Sca-1 + CD45 + cells and Sca-1 − CD45 + cells (D) and between aortic Sca-1 + CD45 + cells and Sca-1 + CD45 − cells (E). July 18, 2014 compared with Sca-1 − CD45 + and Sca-1 + CD45 − cells, respectively ( Figure 2C ). These covered a broad range of biological pathways, including hematopoiesis, inflammation, innate and acquired immunity, and extracellular matrix metabolism, all of which are central to vascular maintenance and disease ( Figure 2D and 2E). Quantitative reverse transcription polymerase chain reaction validation of 12 of these gene products provided a Spearman r coefficient of 0.712 (P<0.01) with the microarray (Online Table II ).
We used flow cytometry to characterize the hematopoietic surface markers of these subpopulations. Compared with the other Sca-1/CD45 subpopulations in adult C57BL/6 aorta, a higher percentage of Sca-1 + CD45 + cells expressed CX 3 CR1, CD115 (c-fms), and c-Kit (CD117), which are established markers of MDPs and cMoPs in BM 7, 8 (Figure 3A , Online Figure VIII ). Further immunophenotypic characterization was then performed to examine for MDP-like (Lin − c-Kit + CD135 + CD115 + CX 3 CR1 + ) 7 and cMoP-like (Lin − c-Kit + CD135 − CD115 + CX 3 CR1 + Ly6C + CD11b − ) 8 surface marker profiles within the aortic Sca-1 + CD45 + fraction, where the panel of lineage markers used was CD31, NK1.1, CD3, CD19, CD11c, Ly6G, Ter119, and a live-dead marker. Although expression of the MDP-like markers accounted for <5 per 100 000 aortic cells, the aortic Sca-1 + CD45 + gate was found to contain a well-delineated subpopulation of cMoP-like cells ( Figure 3B ). The frequency of these Sca-1 + CD45 + Lin − c-Kit + CD135 − CD115 + CX 3 CR1 + Ly6C + CD11b − cells in C57BL/6 aorta was in the order of 15 to 30 per 100 000 cells, which approximated the frequency of CFU-M from unfractionated aortic cell culture (see Figure 1A ). This subpopulation contained a high proportion of Ki67 + cells (69.6±3.2%, n=9 mice), consistent with a proliferative progenitor (as distinct from quiescent stem cell) phenotype ( Figure 3B) .
Collectively, the above data indicate the distinctive genotypic and phenotypic profiles portended by the dual expression of Sca-1 and CD45 on aortic cells. The CFU-M-enriched Sca-1 + CD45 + fraction expresses immunophenotypic markers consistent with macrophage ancestry and includes a small subfraction of proliferative Lin − c-Kit + CD135 − CD115 + CX 3 CR 1 + Ly6C + CD11b − cells that has been identified as cMoP-like.
Maintenance of Aortic CFU-M Progenitors Is Not From Circulating Cells
Our data suggest that a key difference between macrophage ancestors in BM and spleen and CFU-M progenitors in aorta is that the latter express Sca-1, as this marker is known to be downregulated and ultimately lost with progression of BM hematopoiesis to lineage specification. 7 This prompted us to investigate whether postnatal aortic Sca-1 + CD45 + cells and their CFU-M progeny are maintained by circulatory trafficking from BM or spleen. In the first instance, we noted that isolation of Sca-1 + CD45 + cells from BM and spleen yielded completely different CFU profiles that lacked the CFU-M specificity of the Sca-1 + CD45 + fraction in aorta (Online Figure  IX) . Then BM or splenic cells from GFP donors were transferred intravenously to lethally irradiated C57BL/6 mice. In both sets of adoptive transfer experiments, there was rapid reconstitution of blood with GFP + cells (85.8±2.8% at 2 weeks and 94.4±0.6% at 12 weeks; n=8). By 16 weeks, chimerism of GFP + cells in whole aorta was 15.9±3.8%, contributing to 42.9±6.9% of the aorta's Sca-1 + CD45 + compartment but to few CD45 − cells ( Figure 4A , Online Figure X ). As consistent with our previous experience, 15 Figure 1A) , indicating radiosensitivity. These aortic colonies remained predominantly CFU-M (920/982; 93.7%), with the majority still recovered from Sca-1 + CD45 + cells (796/920; 86.5%). Despite nearly complete GFP reconstitution of blood monocytes, donor GFP + cells contributed to only 3.3% (30/920) of all aortic CFU-M and 1.0% (8/796) of CFU-M generated from aortic Sca-1 + CD45 + cells (n=8 experiments; Figure 4A , Online Figure XC) . Therefore, although circulating cells contributed to the aorta's Sca-1 + CD45 + population, those Sca-1 + CD45 + cells responsible for CFU-M capacity were of host origin and not the result of recruitment to the vessel wall from BM-or splenic-derived cells. In contrast, 90.3% (56/62) of nonmacrophage colonies, including CFU-GM and -GEMM that were mostly generated from aortic Sca-1 − cells, were of donor GFP + source. These results indicate mixed sources of hematopoietic CFUs in aorta. Circulatory surveillance of BM and splenic hematopoietic stem cells/ HPCs is largely responsible for the aorta's rare content of CFU-granulocyte, -GM, -GEMM, and burst-forming unitserythroid, consistent with the previous model proposed by Massberg et al. 19 In contrast, Sca-1 + CD45 + CFU-M progenitors, which are much more prevalent in aorta, are inefficiently reconstituted from BM and spleen, suggesting that they may be maintained locally.
Importantly, in these experiments we also observed that aortic CD11b + F4/80 Hi macrophages were equally of both donor and recipient origin 16 weeks after irradiation and adoptive transfer (49.4±5.5% GFP + ; Figure 4A ). This suggested the contribution of a local source to aortic macrophages, as has been shown recently for resident macrophages in other organs. 12 At the same time, it also provided additional evidence to dismiss the possibility that macrophages in the vessel wall were responsible for generating CFU-M, because 96.7% of these colonies were GFP − ( Figure 4A , Online Figure XC) .
To further corroborate that aortic Sca-1 + CD45 + CFU-M progenitors cannot be attributed to the recruitment of circulating monocytes or the presence of proliferative macrophages in the vessel wall, we studied 2 different models of monocyte/ macrophage depletion: (1) liposomal clodronate treatment 4 ( Figure 4B ) and (2) osteopetrotic (op/op) mice that are genetically deficient in M-CSF 20 (Figure 4C and 4D, Online Figure  XI) . Previously, clodronate treatment has been shown to result in virtual disappearance of circulating monocytes within 24 hours. 4 We repeatedly administered liposomal clodronate to adult C57BL/6 mice for 30 days, because this time period exceeds the interval thought to be required for macrophage turnover in postnatal murine tissues, including atherosclerotic aorta. 4, 12 Despite resulting in marked reduction of circulating monocytes, clodronate treatment was in fact associated with a small but significant increase in the frequency of CFU-M generated from aortic cell cultures ( Figure 4B ), providing more evidence that blood-derived monocytes are not the source of aortic CFU-M progenitors.
In comparison with wild-type littermates, aortas from weaning-age M-CSF-deficient op/op mice had preserved numbers of Sca-1 + CD45 + cells ( Figure 4C ) and generated similar frequencies of CFU-M under standard colony outgrowth conditions (ie, without addition of M-CSF; Figure 4D ), despite the expected reduction in their frequency of circulating monocytes, as well as monocytes and macrophages in spleen (Online Figure XI) and aorta ( Figure 4C ). These results affirm that the aorta's capacity to produce CFU-M is independent of cells that are reduced in op/op mice, namely circulating monocytes and monocytes and macrophages that are resident in the aortic wall. Op/op mice also had markedly diminished CFU yield from BM attributable to osteopetrosis, but enhanced hematopoiesis in spleen, resulting from displacement of hematopoietic stem cells and HPCs from BM (Online Figure XI) . Interestingly, yield of nonmacrophage colonies, especially CFU-GM and -GEMM, was increased from op/op aortas ( Figure 4D ), demonstrating that extramedullary hematopoiesis impacted the frequency of multilineage HPCs in aorta but not macrophage-specific progenitors.
Aortic Sca-1 + CD45 + Macrophage Progenitors Are Upregulated in Atherosclerosis
Hyperlipidemia has been shown to have a stimulatory effect on BM hematopoietic stem cells/HPCs, providing potential mechanistic insight into leukocyte upregulation in atherosclerotic vessels. 21 However, recent evidence has suggested a switch in the predominant source of macrophages in atheroma of ApoE −/− mice from circulating monocytes in early lesion development to local macrophage proliferation in established intimal lesions. 4 By comparison with age-matched C57BL/6 mice, we observed an increase in the frequency of Sca-1 + CD45 + cells from disaggregates of whole aorta from 5-month-old ApoE −/− mice, especially in those fed 12 weeks of Western diet (WD; Figure 5A , Online Figure XII) . The aortas of these hyperlipidemic mice also contained increased adventitial levels of M-CSF, as determined by quantitative ELISA (Online Figure XIIB) , along with increases in the generation of CFU-M (1.8-fold for chow diet ApoE −/− relative to C57BL/6; 2.3-fold for WD ApoE −/− relative to C57BL/6; Figure 5B ), but not other CFU subtypes (data not shown). Similar results were observed for LDL-R −/− mice (Online Figure XIII) .
Because the spleen has been implicated as an important reservoir from which proinflammatory monocytes are recruited to generate macrophages in atherosclerosis 22, 23 and myocardial infarction, 24 we also interrogated the frequency of CFU-M progenitor cells in aortas of splenectomized mice. Neither CFU-M, Sca-1 + CD45 + , macrophage nor dendritic cell frequencies were found to be diminished in healthy, atheroprone or atherosclerotic aortas, 3 months after splenectomy, despite the anticipated reduction that splenectomy caused to aortic monocyte content ( Figure 5A-5C ). These data are consistent with those from our splenic cell adoptive transfer studies (Online Figure X) in verifying that the spleen is not a significant source of aortic macrophage progenitors via supply of circulating HPCs or monocytes.
We next set out to define the distribution of local macrophage progenitor cells during murine atherosclerosis development. In aortas from C57BL/6 and prelesional chow diet ApoE −/− mice, Sca-1 + CD45 + cells were almost exclusively contained within the adventitia. After 12 weeks of WD, ApoE −/− and LDL-R −/− aortas displayed transmural distribution of Sca-1 + CD45 + cells, also involving media and lesional neointima ( Figure 5D, Online Figures XII and XIII) . Despite the presence of Sca-1 + CD45 + cells and macrophages in neointimal plaque, the great majority of CFU-M from WD ApoE −/− aortas were still derived from adventitia, as determined when the adventitia was separated by microscopic dissection from the remaining vessel wall before digestion and culture ( Figure 5E ). Quantification of Ki67 nuclear expression in sections of atheroma-containing aortic root revealed that almost 75% of proliferating (Ki67 + ) cells were located within the adventitia, the confines of which we defined as being within 5 cell layers from the external elastic lamina (Figure 5F and 5G). Of the 11.0±1.0% of adventitial cells that were Ki67 + ( Figure 5H) , a majority were Sca-1 + CD45 + (63.7±5.4% from 14 sections, 3 mice; Figure 5I , Online Movie I). In contrast, only 5.3±1.3% of cells in atheroma itself were Ki67 + (P<0.001 versus adventitia), with 65.2±11.8% of these being Sca-1 − CD45 + . Overall, microscopic quantification of Ki67 staining for aortic root revealed that the highest proportion of actively cycling cells in WD ApoE −/− aorta was contained within the Sca-1 + CD45 + population, followed by Sca-1 − CD45 + cells ( Figure 5I ). In keeping with the predominantly adventitial distribution of CFU-M progenitors in WD aorta, a higher percentage of adventitial Sca-1 + CD45 + cells were proliferative than was the case for Sca-1 + CD45 + cells in plaque (15.4±1.5% versus 1.8±0.6%; P<0.0001). By flow cytometry assessment of bromodeoxyuridine incorporation in disaggregates of whole aorta from WD ApoE −/− mice, 19.8±1.2% of Sca-1 + CD45 + cells were in the S or G 2 /M phases of cycle (n=10; Figure 5J ). Taken together, these observations reveal spatial diversity and heterogeneity of Sca-1 + CD45 + cells within atherosclerotic aorta, highlighting that the majority of clonogenic and proliferative Sca-1 + CD45 + macrophage progenitors do in fact remain in the adventitia.
Sca-1 + CD45 + AMPCs Have Durable MPS Cell Fate
Finally, to interrogate the in vivo fate of Sca-1 + CD45 + cells within atherosclerotic arteries, we isolated cells by Sca-1 and CD45 expression from aortas of GFP mice and injected each fraction into carotid artery adventitia of recipient 8-weekold ApoE −/− mice ( Figure 6A ). WD was then administered for 16 weeks, during and after which GFP + donor cells were not detectable systemically ( Figure 6B ). At study end, donor-derived cells were identified in the injected artery of all recipients of Sca-1 + CD45 + cells (n=7 mice; Figure 6C ) to a greater extent than was the case 48 hours after their administration ( Figure 6A ). From all carotid artery sections examined from GFP + Sca-1 + CD45 + recipients, 89.4% (583/652) of GFP + cells were located in adventitia and 10.6% (69/652) in plaque ( Figure 6D ), although the latter was increased to 18.6% (69/371) in sections that actually contained atheroma. Of the cells enumerated in atheroma, 7.5±3.5% of cells were GFP + , and 22.6±4.4% of all cells in adventitia were GFP + ( Figure 6E ). Phenotypic analysis revealed active cycling (Ki67 + ) of some donor-derived cells (Online Figure XIV) , as well as expression of macrophage (F4/80, monocyte/macrophage antibody-2 [MOMA-2]) and dendritic cell (CD11c) markers ( Figure 6F ). By comparison, GFP was absent after injection of cell-free matrigel and was rarely identified after transfer of Sca-1 − CD45 + or Sca-1 + CD45 − cells ( Figure 6C ). Although this in vivo model revealed the striking capacity of Sca-1 + CD45 + cells to engraft after allogeneic transfer and provide long-term MPS progeny in their new environment, our findings suggest that the major contribution of these progenitors is to the maintenance of the adventitial, rather than neointimal, macrophage compartment, which is known to expand in atherosclerosis and play an important regulatory role in pathogenic processes, such as vasa vasorum formation. 2
Discussion
Prevailing concepts of macrophage development recognize that there are diverse origins for different cellular subtypes of the MPS. 5 In particular, growing evidence indicates that circulating monocytes, and by extension BM MDPs, are not the sole source of resident macrophages in many postnatal tissues. 6, 9, 11, 12 Although recent emphasis has focused on the capacity of mature macrophages to undergo self-renewal and local proliferation, 4, 13 an alternative inference of these observations is that there may exist local niches of tissue-resident, nonmedullary macrophage progenitor cells that persist through adult life. To address this, the current study used murine aorta as a template for the interrogation of tissue macrophage progenitor cells.
Using hematopoietic CFU assays, along with a combination of genetic, phenotypic, and functional analyses, we discovered the existence of a distinct population of clonogenic adventitial progenitors that coexpress Sca-1 and CD45, are strongly predisposed to generate MPS cells, and lack granulocyte potential. A significant proportion of these cells are actively cycling in situ at any given time, under both healthy and atherosclerotic conditions. Consistent with recent evidence on the local origins of postnatal tissue macrophages, these AMPCs are not the result of circulatory trafficking of HPCs. Just as importantly, multiple lines of evidence suggest that their existence cannot be interpreted as the proliferation of monocytes recruited from the peripheral blood or the self-renewal and rapid turnover of resident mature macrophages. First, others have shown that proliferative monocytes 8 and mature macrophages from wild-type mice are not capable of forming CFU-M. 25 Second, although of variable size, the CFU-M generated by aortic Sca-1 + CD45 + cells frequently comprise hundreds to thousands of cells and in prior adoptive transfer experiments have displayed remarkable long-lasting and self-renewing properties, months after primary and secondary transplantation. 15 Third and fundamentally, in the present study, lineage-positive aortic cells, including those that expressed CD11b, showed minimal capacity to generate CFU-M unlike their Lin − counterparts, while the frequency of CFU-M was 16 times lower from Sca-1 − CD45 + cells than Sca-1 + CD45 + cells, despite higher monocyte content in the former. Fourth, neither clodronatetreated C57BL/6 mice nor M-CSF-deficient mice displayed diminished aortic CFU-M yield. Fifth, in adoptive BM and splenic transfer experiments, recipient mice had ≈95% chimeric reconstitution of circulating monocytes with an almost equal mixture of donor-and recipient-derived macrophages in aorta, yet produced only 3.3% donor-derived aortic CFU-M. Sixth, aortic CFU-M were not diminished in splenectomized mice despite their reduced vessel wall content of monocytes and Ly6C Hi monocytes. Finally, despite the presence of macrophages in atherosclerotic neointima, the CFU-M capacity of aortas from WD ApoE −/− mice was predominantly contained within the adventitia.
Unlike previous work reporting the presence of arterial Sca-1 + CD45 − smooth muscle progenitor cells, 17 our data draw attention to the fact that a considerable proportion of adventitial Sca-1 + cells express CD45 and it is within this highly heterogeneous fraction that macrophage clonogenicity is primarily contained. These cells are transcriptionally and functionally distinct from their neighboring CD45-negative counterparts. As is the case for proliferative, self-renewing microglia in the central nervous system (CNS), 10 our results in the op/op mice indicate that the presence of Sca-1 + CD45 + AMPCs is not dependent on M-CSF, although we have shown that this factor does facilitate their ability to generate CFU-M and differentiate to macrophages. Intriguingly, the presence of Sca-1 on the surface of vascular AMPCs directly contravenes classical hierarchical depictions of murine BM hematopoiesis, where Sca-1 is absent from lineage-committed myeloid precursor cells, including granulocyte-macrophage progenitors and MDPs. 7 However, in keeping with the profiles ascribed to Sca-1 − BM MDPs and cMoPs, 8 this study demonstrates that the adventitial Sca-1 + CD45 + population does contain cells that express c-Kit, CX 3 CR1, and CD115 and moreover a small subset of cMoPlike Lin − c-Kit + CD135 − CD115 + CX 3 CR1 + Ly6C + CD11b − cells, which are highly proliferative and whose frequency approximates the yield of CFU-M from healthy aortas. Isolation of these rare cells from fresh aortic disaggregates by multicolor fluorescence-activated cell sorting to test their clonogenicity has thus far proven extremely challenging because of difficulties in preserving cell viability. However, it remains an important objective to further delineate the specific identify of the clonogenic AMPC subpopulation moving forward.
Although our adoptive transfer model may have been confounded by the effects of irradiation, it demonstrated that BM and splenic HPCs contribute minimally to the presence of CFU-M progenitors in postnatal aorta. Even with compromised clonal capacity after irradiation, 96.7% CFU-M and 50% of aortic macrophages were still host-derived 16 weeks after BM or splenic cell transfer, suggesting substantial local contribution. It is presumed that these macrophages were generated in the vessel wall after irradiation and were not already pre-existent there, because recent profiling of tissue and vascular macrophage kinetics has shown substantial turnover within 21 to 28 days. 4, 12 Future studies dedicated to investigating the BM independence of AMPCs and macrophage responses in healthy and diseased vasculature will require molecular fatemapping strategies, similar to those used to investigate the origins of other tissue macrophages. 6, 9, 12 Circulating monocytes and their BM-derived progenitor cells have long been considered the source of intimal macrophages and foam cells in atheroma, 1 whereas the spleen has also been recognized as an intermediate reservoir of monocytes. 22 The present study reveals that in both mild and severe hyperlipidemia, aortic frequency of Sca-1 + CD45 + expression and CFU-M yield progressively increase and this is not affected by surgical removal of the spleen and its accompanying reduction in vessel wall monocyte content. In lesional ApoE −/− and LDL-R −/− sections, we observed substantial proliferation along the adventitial aspect of the external elastic lamina, especially within the Sca-1 + CD45 + population. Interestingly, although Sca-1/CD45 costaining breaches the adventitia in the setting of atheroma to involve the other mural layers, the progenitors responsible for CFU-M are still mostly adventitial. Taken together with the findings from our BM transplant studies, it is apparent that there is great diversity in the biological properties and origins of Sca-1 + CD45 + cells in the vessel wall. We conclude that the vast majority of Sca-1 + CD45 + cells in atheroma are neither AMPCs nor the result of adventitial-to-neointimal translocation of AMPC progeny, but are more likely to be leukocytes and lymphocytes that have originated from the circulation. The results of our carotid adventitial transfer model show that donor Sca-1 + CD45 + cells, but not the other aortic subsets, generated macrophages and dendritic cells 16 weeks after delivery, although these were predominantly adventitial. This fits with the proliferative, clonogenic nature of Sca-1 + CD45 + AMPCs, which are located to be able to contribute to the presence of MPS populations found in the adventitia of healthy arteries, 16 as well as the rapid expansion of adventitial macrophages that occurs during the development of atherosclerosis and aneurysms, where these cells also help regulate growth of pathogenic vasa vasorum. 2, 26, 27 We are currently focusing on the proangiogenic properties of Sca-1 + CD45 + AMPCs, which we hypothesize may underlie one of their major pathophysiological functions during arterial wall remodeling. Although our results indicate that adventitial progenitors may contribute to only a small proportion of neointimal leukocytes, alternative model systems, such as molecular fate-mapping and arterial graft interposition, will be required before definitively excluding a greater role for AMPCs as a source of locally maintained macrophages in atheroma. 4 In summary, we have identified a population of Sca-1 + CD45 + macrophage progenitor cells that reside in postnatal murine vascular adventitia. The definition of these resident progenitors provides a new context to consider the role of the adventitia in vascular disease, including atherosclerosis. Moreover, it provides a novel alternative paradigm to account for the local proliferation and turnover of tissue macrophages, advancing our understanding of the vessel wall as a source of tissue-resident macrophages and their progenitors more broadly.
